ADGRL4 and glioma: As shown in Table 2, using Univariate Cox regression analyses, ELTD1 overexpression was related to a notably increased risk of tumor recurrence in glioma patients (P = 0.03) compared to the risk of recurrence in patients with low expression levels (Table 2).